Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

72.96
-1.3800-1.86%
Post-market: 73.930.9700+1.33%18:22 EDT
Volume:688.41K
Turnover:49.52M
Market Cap:2.09B
PE:-7.50
High:73.93
Open:73.59
Low:70.67
Close:74.34
52wk High:77.00
52wk Low:6.48
Shares:28.69M
Float Shares:26.24M
Volume Ratio:1.00
T/O Rate:2.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7300
EPS(LYR):-8.6765
ROE:-217.94%
ROA:-27.98%
PB:23.30
PE(LYR):-8.41

Loading ...

Nektar Therapeutics Announces Chief Legal Officer Departure

TIPRANKS
·
Nov 22, 2025

Nektar Therapeutics Names Elizabeth Zhang as Chief Legal Officer

Reuters
·
Nov 22, 2025

Nektar Therapeutics Q3 EPS USD -1.87

Reuters
·
Nov 20, 2025

Nektar Therapeutics (NKTR): Assessing Valuation After $110 Million Equity Offering and New Shelf Registrations

Simply Wall St.
·
Nov 17, 2025

Nektar Therapeutics: Buy Rating Driven by Promising REZPEG Data and Favorable Safety Profile in Alopecia Areata Treatment

TIPRANKS
·
Nov 16, 2025

Nektar Therapeutics - May Sell Shares Worth up to $110 Mln - SEC Filing

THOMSON REUTERS
·
Nov 13, 2025

Nektar Therapeutics - Enters Equity Distribution Agreement With Piper Sandler & Btig - SEC Filing

THOMSON REUTERS
·
Nov 13, 2025

Nektar files automatic mixed securities shelf

TIPRANKS
·
Nov 13, 2025

Nektar Therapeutics Files for Mixed Shelf Offering, Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Nov 13, 2025

H.C. Wainwright Reaffirms Their Buy Rating on Nektar Therapeutics (NKTR)

TIPRANKS
·
Nov 11, 2025

PharmaEssentia Appoints Dr. Barry Flannelly as Independent Director

Reuters
·
Nov 10, 2025

Nektar Therapeutics Reports Positive Phase 2b Results for Rezpegaldesleukin in Atopic Dermatitis and Asthma

Reuters
·
Nov 10, 2025

Stock Track | Nektar Therapeutics Soars 5.43% Pre-market, Extending Recent Rally Amid Bullish Analyst Forecasts

Stock Track
·
Nov 10, 2025

Stock Track | Nektar Therapeutics Soars 5.43% in Pre-market Trading Amid Bullish Sentiment and Valuation Debate

Stock Track
·
Nov 10, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), Sana Biotechnology (SANA) and Nektar Therapeutics (NKTR)

TIPRANKS
·
Nov 10, 2025

Assessing Nektar Therapeutics (NKTR) Valuation After Recent Surge in Share Price

Simply Wall St.
·
Nov 10, 2025

Nektar presents new data from REZOLVE-AD study of ACAAI

TIPRANKS
·
Nov 10, 2025

Stock Track | Nektar Therapeutics Surges 5.22% Pre-Market on Strong Q3 Results and Pipeline Progress

Stock Track
·
Nov 07, 2025

Stock Track | Nektar Therapeutics Soars 5.22% Pre-Market on Strong Q3 Results and Pipeline Progress

Stock Track
·
Nov 07, 2025

Stock Track | Nektar Therapeutics Soars 7.04% After-Hours on Strong Q3 Results and Promising Pipeline Progress

Stock Track
·
Nov 07, 2025